Skip to main content
. 1998 Jun 20;316(7148):1858–1863. doi: 10.1136/bmj.316.7148.1858

Table 2.

Odds ratios of hip fracture with use of hormone replacement therapy

Use of hormone replacement therapy Any
Without progestin
With progestin
No of cases/ Odds ratio* No of cases/ controls Odds ratio* No of cases/ controls Odds ratio*
controls (95% CI) (95% CI) (95% CI)
Never 956/2073 1.00 (reference) 956/2073 1.00 (reference) 956/2073 1.00 (reference)
Ever: 120/456  0.58 (0.46 to 0.75) 81/229 0.69 (0.52 to 0.93) 56/274 0.46 (0.32 to 0.66)
 Current 40/239 0.36 (0.24 to 0.53) 16/62  0.48 (0.26 to 0.87) 24/17  0.29 (0.17 to 0.48)
 Former 80/217 0.76 (0.57 to 1.01) 65/167 0.76 (0.56 to 1.04) 32/9   0.71 (0.46 to 1.12)
Per year of use:
 Ever 0.94 (0.91 to 0.97) 0.96 (0.92 to 0.99) 0.89 (0.84 to 0.94)
 Current 0.91 (0.87 to 0.95) 0.94 (0.88 to 0.99) 0.84 (0.76 to 0.92)
 Former 0.97 (0.93 to 1.02) 0.98 (0.92 to 1.04) 0.93 (0.85 to 1.02)
*

Adjusted for age (50 to 54, 55 to 59, 60 to 64, 65 to 69, 70 to 74, 75 to 81 years) and the indication of hormone replacement therapy to prevent osteoporosis (yes/no).